Keyword: Aravive Biologics
Former Aravive Chairman Ray Tabibiazar will serve as senior vice president of corporate development and business strategy at Twist Bioscience.
Aravive will merge with the struggling Versartis and gain access to the Nasdaq
Seattle Genetics names Keytruda developer as CMO and Aravive CEO Stephen Eck leaves to join Immatics.
Former Astellas and Aravive executive Stephen Eck, M.D., Ph.D., has jumped ship to Immatics US as its new chief medical officer.
The preclinical biotech’s leading program is focused on blocking the GAS6/AXL pathway, activation of which plays a critical role in multiple types of cancer malignancies that help the spread of the disease and cell survival.
The philosophy of Fierce 15 is a simple one: We want to see the best science combined with the brightest teams, and we want to see the promise that they hold in their hands has a genuine chance of being the Next Big Thing. Here are this year's standouts.